Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares The company has been maintaining a healthy dividend payout of 18 per cent. DSIJ Intelligence-1 / Sunday, April 20, 2025 / Article rating: 3.6 The company has a market cap of Rs 39,728 crore where Kiran Mazumdar Shaw (promoter of the company) holds a 40.36 per cent stake in the company.
Sensex Gains 300 Points, Nifty Crosses 200-DEMA; PSU Banks Outperform Sensex Gains 300 Points, Nifty Crosses 200-DEMA; PSU Banks Outperform Market breadth indicators show that 54 stocks touched their 52-week highs, whereas only 11 stocks hit their 52-week lows. DSIJ Intelligence-2 / Wednesday, April 16, 2025 / Article rating: 5.0
Sensex and Nifty Jump After Long Weekend on Global Cues Sensex and Nifty Jump After Long Weekend on Global Cues Broader indices, including small-cap and mid-cap stocks, moved up, gaining 1.3 per cent each. DSIJ Intelligence-2 / Tuesday, April 15, 2025 / Article rating: 2.0
The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent. DSIJ Intelligence-2 / Tuesday, April 15, 2025 / Article rating: 5.0 Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent.
Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon Syngene International Limited has a market capitalization of over Rs 28,000 crore, a 1-year return of 3 per cent, a 3-year return of 25 per cent and a PE ratio of 60. DSIJ Intelligence-1 / Tuesday, March 25, 2025 / Article rating: 4.3 Syngene International Limited has a market capitalization of over Rs 28,000 crore, a 1-year return of 3 per cent, a 3-year return of 25 per cent and a PE ratio of 60.
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. DSIJ Intelligence / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
Low PE & High ROE Stock: This bio-pharma company signs commercialization agreement with Juno Pharmaceuticals in Canada! Low PE & High ROE Stock: This bio-pharma company signs commercialization agreement with Juno Pharmaceuticals in Canada! The shares of the company have a PE of 11.03x and an ROE of 31.94 per cent with multibagger returns of 375 per cent in a decade. DSIJ Intelligence-1 / Saturday, October 7, 2023 / Article rating: 3.3 The shares of the company have a PE of 11.03x and an ROE of 31.94 per cent with multibagger returns of 375 per cent in a decade.
Overnight Digest: Stocks to keep an eye on December 01! Overnight Digest: Stocks to keep an eye on December 01! Watch out for these stocks in Thursday’s trading session! DSIJ Intelligence / Wednesday, November 30, 2022 / Article rating: 4.1 Watch out for these stocks in Thursday’s trading session!
Overnight Digest: Stocks to keep an eye on November 25! Overnight Digest: Stocks to keep an eye on November 25! Watch out for these stocks in Friday’s trading session! DSIJ Intelligence / Thursday, November 24, 2022 / Article rating: 4.6 Watch out for these stocks in Friday’s trading session!